86 related articles for article (PubMed ID: 8090901)
21. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
23. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
[TBL] [Abstract][Full Text] [Related]
24. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
Chen YW; Yen SH; Chen SY; Huang PI; Shiau CY; Liu YM; Lin JK; Wang LW
J Surg Oncol; 2007 Oct; 96(5):374-80. PubMed ID: 17492635
[TBL] [Abstract][Full Text] [Related]
25. Carcinoma of the anus treated with primary radiation therapy and chemotherapy.
Johnson D; Lipsett J; Leong L; Wagman LD; Terz JJ
Surg Gynecol Obstet; 1993 Oct; 177(4):329-34. PubMed ID: 8211574
[TBL] [Abstract][Full Text] [Related]
26. [Cancer of the anal canal].
Ruíz Molina JM; Gómez Aceytuno R; Gallardo Rincón D; Herrera R; Mondragón Sánchez RJ; Oñate Ocaña LF; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1997; 62(3):184-8. PubMed ID: 9480525
[TBL] [Abstract][Full Text] [Related]
27. Anal neoplasia in persons with HIV infection.
Northfelt DW
AIDS Clin Care; 1996 Aug; 8(8):63-6. PubMed ID: 11363714
[TBL] [Abstract][Full Text] [Related]
28. [Function-preserving treatment of anal cancer using simultaneous radio- and chemotherapy].
Dunst J; Reichard U; Wolf N; Sauer R
Dtsch Med Wochenschr; 1987 Jul; 112(31-32):1201-5. PubMed ID: 3111816
[TBL] [Abstract][Full Text] [Related]
29. Combining cisplatin and mitomycin with radiotherapy in anal carcinoma.
Crehange G; Bosset M; Lorchel F; Dumas JL; Buffet-Miny J; Puyraveau M; Mercier M; Bosset JF
Dis Colon Rectum; 2007 Jan; 50(1):43-9. PubMed ID: 17089083
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the anal margin: the university of Florida experience.
Balamucki CJ; Zlotecki RA; Rout WR; Newlin HE; Morris CG; Kirwan JM; George TJ; Mendenhall WM
Am J Clin Oncol; 2011 Aug; 34(4):406-10. PubMed ID: 20881476
[TBL] [Abstract][Full Text] [Related]
31. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
[TBL] [Abstract][Full Text] [Related]
32. [Four cases of anal squamous cell carcinoma treated by chemoradiotherapy].
Sato H; Maeda K; Koide Y; Matsuoka H; Noro T; Honda K; Shiota M; Endo T; Ozeki S; Fukuda M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2647-9. PubMed ID: 21224667
[TBL] [Abstract][Full Text] [Related]
33. [Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].
Shiozawa M; Nishimura K; Nonaka T; Yoshii T; Nakayama N; Motohashi O; Takagi S; Nakayama Y; Akaike M
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2941-3. PubMed ID: 21160276
[TBL] [Abstract][Full Text] [Related]
34. The bottom line: outcomes after conservation treatment in anal cancer.
Dwyer MK; Gebski VJ; Jayamohan J
Australas Radiol; 2006 Feb; 50(1):46-51. PubMed ID: 16499727
[TBL] [Abstract][Full Text] [Related]
35. Epidermoid anal cancer in HIV infected patients.
Bottomley DM; Aqel N; Selvaratnam G; Phillips RH
Clin Oncol (R Coll Radiol); 1996; 8(5):319-22. PubMed ID: 8934052
[TBL] [Abstract][Full Text] [Related]
36. Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma--clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network.
DeFoe SG; Beriwal S; Jones H; Rakfal S; Heron DE; Kabolizadeh P; Smith RP; Lalonde R
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):424-31. PubMed ID: 22075444
[TBL] [Abstract][Full Text] [Related]
37. Amifostine and curative intent chemoradiation for compromised cancer patients.
Nguyen NP; Levinson B; Dutta S; Karlsson U; Kelly KC; Dowell J; Ludin A; Sallah S
Anticancer Res; 2003; 23(2C):1649-56. PubMed ID: 12820436
[TBL] [Abstract][Full Text] [Related]
38. Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
Zilli T; Schick U; Ozsahin M; Gervaz P; Roth AD; Allal AS
Radiother Oncol; 2012 Jan; 102(1):62-7. PubMed ID: 21993403
[TBL] [Abstract][Full Text] [Related]
39. [Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis].
Vatra B; Sobhani I; Aparicio T; Girard PM; Puy Montbrun TD; Housset M; Baillet F; Hecht F; Chossidow D; Soulé JC
Gastroenterol Clin Biol; 2002 Feb; 26(2):150-6. PubMed ID: 11938066
[TBL] [Abstract][Full Text] [Related]
40. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.
Hoffman R; Welton ML; Klencke B; Weinberg V; Krieg R
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):127-31. PubMed ID: 10219805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
